EU can do more for patients with smart use of biosimilar medicines

Related Posts

• European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
• Smart use of off-patent medicines will be critical… 7 October 2021 Open
• Smart policies will encourage more critical… 26 February 2021 Open
• Educational material on biosimilar medicines,… 2 November 2020 The era of biological medicinesSince their first use in the…